Table 3. Predictors of baseline syndecan-1.
Unadjusted | Adjusted p<0.1 | |||||
---|---|---|---|---|---|---|
Beta | p | 95% CI | Beta | p | 95% CI | |
Female | 7.845 | 0.628 | -24.692–40.382 | -4.039 | 0.860 | -1.638–1.951 |
Age | 0.173 | 0.849 | -1.654–2.001 | 0–156 | 0.860 | -1.638–1.951 |
aTNF+MTX vs MTX | 15.590 | 0.313 | -15.303–46.483 | |||
CRP | 0.881 | 0.043 | 0.028–1.735 | 1.212 | 0.014 | 0.265–2.159 |
LDL-C | 12.722 | 0.087 | -1.923–27.367 | 18.524 | 0.021 | 2.956–34.091 |
RHI | 1.379 | 0.069 | -39.293–42.050 | 1.730 | 0.930 | -41.546–38.086 |
TNFi: Anti-tumor necrosis factor; MTX: Methotrexate; CRP: C-reactive protein; LDL-C: Low-density lipoprotein cholesterol; RHI: Reactive hyperaemic index.